Laboratory Corporation of America Holdings Dirección
Dirección controles de criterios 4/4
El CEO de Laboratory of America Holdings' es Adam Schechter , nombrado en Nov 2019, tiene una permanencia de 4.42 años. compensación anual total es $15.98M, compuesta por 8.6% salario y 91.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.11% de las acciones de la empresa, por valor de $19.47M. La antigüedad media del equipo directivo y de la junta directiva es de 4.3 años y 10.2 años, respectivamente.
Información clave
Adam Schechter
Chief Executive Officer (CEO)
US$16.0m
Compensación total
| Porcentaje del salario del CEO | 8.6% |
| Permanencia del CEO | 4.5yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 4.3yrs |
| Promedio de permanencia en la Junta Directiva | 10.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16Laboratory Corporation of America declares $0.72 dividend
Jan 12Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up
Dec 07Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?
Nov 24Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth
Nov 08Laboratory Corporation of America Q3 2022 Earnings Preview
Oct 26We Think Laboratory Corporation of America Holdings (NYSE:LH) Can Stay On Top Of Its Debt
Oct 14Laboratory Corporation of America declares $0.72 dividend
Oct 12Is Laboratory Corporation of America Holdings (NYSE:LH) Potentially Undervalued?
Sep 28Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$399m |
| Dec 31 2023 | US$16m | US$1m | US$379m |
| Sep 30 2023 | n/a | n/a | US$583m |
| Jun 30 2023 | n/a | n/a | US$677m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$15m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$21m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$3b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$15m | US$1m | US$2b |
| Sep 30 2020 | n/a | n/a | US$845m |
| Jun 30 2020 | n/a | n/a | US$362m |
| Mar 31 2020 | n/a | n/a | US$321m |
| Dec 31 2019 | US$6m | US$208k | US$824m |
| Sep 30 2019 | n/a | n/a | US$755m |
| Jun 30 2019 | n/a | n/a | US$853m |
| Mar 31 2019 | n/a | n/a | US$896m |
| Dec 31 2018 | US$301k | n/a | US$884m |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$290k | n/a | US$1b |
Compensación vs. Mercado: La compensación total ($USD15.98M) de Adam está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD13.51M).
Compensación vs. Ingresos: La compensación de Adam ha sido consistente con los resultados de la empresa en el último año.
CEO
Adam Schechter (58 yo)
4.5yrs
Permanencia
US$15,979,355
Compensación
Mr. Adam H. Schechter serves as President & Chief Executive Officer at Laboratory Corporation of America Holdings since November 01, 2019 and serves as its Chairman since May 13, 2020. He serves as Indepen...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 4.5yrs | US$15.98m | 0.11% $ 18.7m | |
| CFO & Executive VP | 9.9yrs | US$4.96m | 0.048% $ 8.1m | |
| Executive VP | less than a year | US$3.80m | 0.0060% $ 1.0m | |
| EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | less than a year | US$3.48m | 0.033% $ 5.6m | |
| Executive VP & Chief Human Resources Officer | 1.3yrs | US$2.56m | 0.00035% $ 59.1k | |
| Senior VP & Chief Accounting Officer | 5.1yrs | sin datos | 0.0054% $ 906.4k | |
| Executive VP and Chief Information & Technology Officer | 10.3yrs | US$2.70m | 0.033% $ 5.6m | |
| Vice President of Investor Relations | no data | sin datos | sin datos | |
| Executive VP | 5.3yrs | sin datos | 0.0091% $ 1.5m | |
| Executive VP & Chief Marketing Officer | 4.2yrs | sin datos | 0.0047% $ 796.7k | |
| Enterprise Chief Scientific Officer & Senior VP | no data | sin datos | sin datos | |
| Chief Medical Officer | 3.3yrs | sin datos | sin datos |
4.3yrs
Permanencia media
59yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de LH se considera experimentado (4.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 11.1yrs | US$15.98m | 0.11% $ 18.7m | |
| Independent Director | 11.3yrs | US$384.99k | 0.014% $ 2.4m | |
| Independent Director | 18yrs | US$340.73k | 0.020% $ 3.3m | |
| Independent Director | 29.1yrs | US$330.31k | 0.021% $ 3.6m | |
| Lead Independent Director | 10.4yrs | US$339.99k | 0.014% $ 2.4m | |
| Independent Director | 8.3yrs | US$319.99k | 0.010% $ 1.7m | |
| Independent Director | 17yrs | US$350.01k | 0.0096% $ 1.6m | |
| Independent Director | 10.1yrs | US$330.01k | 0.010% $ 1.7m | |
| Independent Director | 4.4yrs | US$344.30k | 0.0043% $ 724.1k | |
| Director | less than a year | US$208.42k | 0.000020% $ 3.4k | |
| Independent Director | 3.2yrs | US$330.01k | 0.0027% $ 459.1k | |
| Independent Director | 1.6yrs | US$330.01k | 0.0016% $ 263.3k |
10.3yrs
Permanencia media
62.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de LH son experimentados ( 10.2 años antigüedad media).